Alcohol and Opioids

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

November 9, 2024

Study Completion Date

November 9, 2024

Conditions

Opioid UseAlcohol Drinking

Interventions

DRUG

Alcohol

Active alcohol or placebo, administered orally

DRUG

Opioid Agonist

Active opioid agonist or placebo, administered orally

Trial Locations (1)

University of Kentucky, Lexington

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Sharon Walsh

OTHER

NCT04300751 - Alcohol and Opioids | Biotech Hunter | Biotech Hunter